Novel & Combination therapies in MDS  Results in SF3B1, Cytidine Deaminase Inhibitors, Decitabine

Novel & Combination therapies in MDS Results in SF3B1, Cytidine Deaminase Inhibitors, Decitabine

hematologydebates

1 year
29 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Marlise R. Luskin, MD, MSCE, Johns Hopkins University School of Medicine, discusses Novel & Combination therapies in MDS Results in SF3B1, Cytidine Deaminase Inhibitors, Decitabine at Imedex Great Debates 2018.
Up Next Autoplay